CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DISCOVER project investigates the interactions between cancer cells and immune cells, focusing on death ligand-death receptor signaling. By understanding these mechanisms, the project aims to develop therapeutic strategies that enhance anti-tumor immune responses and improve treatment outcomes.
During tumour development there is a bi-directional communication between cancer cells and immune cells; the process termed tumour immune editing.
The impact is reciprocal, shaping both the visibility and susceptibility of the tumour to immune eradication as well as the ability of the immune effector cells to recognise and launch an immune response against tumour cells.
Death ligand-death receptor signalling is a key mechanism to kill tumour cells during the early stages of tumour development (…
UNIVERSITY OF GALWAY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
CELL STRESS DISCOVERIES LIMITED
Ireland, Galway
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Türkiye, Alsancak Izmir
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Rennes
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Switzerland, Bern
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
